|
Pronunciation |
|
(myoo
PEER oh
sin) |
|
|
U.S. Brand
Names |
|
Bactroban®; Bactroban®
Nasal |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Mupirocin Calcium; Pseudomonic Acid A |
|
|
Pharmacological Index |
|
Antibiotic, Topical |
|
|
Use |
|
Topical treatment of impetigo due to Staphylococcus aureus,
beta-hemolytic Streptococcus, and S.
pyogenes |
|
|
Pregnancy Risk
Factor |
|
B |
|
|
Contraindications |
|
Known hypersensitivity to mupirocin or polyethylene
glycol |
|
|
Warnings/Precautions |
|
Potentially toxic amounts of polyethylene glycol contained in the vehicle may
be absorbed percutaneously in patients with extensive burns or open wounds;
prolonged use may result in over growth of nonsusceptible organisms; for
external use only; not for treatment of pressure sores |
|
|
Adverse
Reactions |
|
1% to 10%:
Local: Burning, stinging, tenderness, edema, pain |
|
|
Drug
Interactions |
|
No data reported |
|
|
Stability |
|
Do not mix with Aquaphor®, coal tar solution, or
salicylic acid |
|
|
Mechanism of
Action |
|
Binds to bacterial isoleucyl transfer-RNA synthetase resulting in the
inhibition of protein and RNA synthesis |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: Topical: Penetrates the outer layers of the skin; systemic
absorption minimal through intact skin
Protein binding: 95%
Metabolism: Extensively to monic acid, principally in the liver and skin
Half-life: 17-36 minutes
Elimination: In urine |
|
|
Usual Dosage |
|
Topical: Children and Adults: Apply small amount to affected area 2-5
times/day for 5-14 days
Nasal: In adults (12 years of age and older), approximately one-half of the
ointment from the single-use tube should be applied into one nostril and the
other half into the other nostril twice daily for 5 days |
|
|
Mental Health: Effects
on Mental Status |
|
None noted |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None noted |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
For external use only. Wash hands before and after application. Apply this
film over affected areas exactly as directed. Avoid getting in eyes. Report
rash; persistent burning, stinging, swelling, itching, or pain.
Breast-feeding precautions: Consult prescriber if
breast-feeding. |
|
|
Nursing
Implications |
|
Not for treatment of pressure sores in elderly patients; contains
polyethylene glycol vehicle |
|
|
Dosage Forms |
|
Ointment, as calcium:
Topical: 2% (15 g, 30 g) |
|
|
References |
|
Blumer JL, Lemon E, O'Horo J, et al,
"Changing Therapy for Skin and Soft Tissue Infections in Children: Have We Come Full Circle?"
Pediatr Infect Dis J, 1987, 6(1):117-22.
Britton JW, Fajardo JE, and Krafte-Jacobs B,
"Comparison of Mupirocin and Erythromycin in the Treatment of Impetigo," J
Pediatr, 1990, 117(5):827-9.
Goldfarb J, Crenshaw D, O'Horo J, et al,
"Randomized Clinical Trial of Topical Mupirocin Versus Oral Erythromycin for Impetigo,"
Antimicrob Agents Chemother, 1988, 32(12):1780-3.
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|